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Abstract
Background Obesity may cause adverse effects on the
respiratory system. The main purpose of this study was to
investigate how various measures of obesity are related to
arterial blood gases and pulmonary function.
Methods This is a cross-sectional study of consecutive
morbidly obese patients with normal lung function. Blood
gas samples were taken from the radial artery after 5 min of
rest with subjects sitting upright. Lung function measure-
ments included dynamic spirometry, static lung volumes,
and gas diffusing capacity.
Results The 149 patients (77% women) had a mean (SD) age
of 43 years (11 years) and BMI of 45.0 kg/m
2 (6.3 kg/m
2).
The meanexpiratoryreserve volume (ERV) was lessthan half
(49%) of predicted value, whilst most other lung function
values were within predicted range. Forty-two patients had an
abnormally low pO2 value (<10.7 kPa [80 mmHg]), while
eight patients had a high pCO2 value (>6.0 kPa [45 mmHg]).
All anthropometric measures correlated significantly with
decreasing pO2 and increasing pCO2 (all P values<0.05).
BMI, neck circumference (NC), and waist circumference
(WC) were negatively correlated with ERV (r=−0.25, −0.19,
−0.21, respectively, all P values<0.05). Multiple linear
regression showed that BMI, WC, and NC were significantly
associated with pO2 after adjustments for age, gender, and
pack-years (all P values<0.001). The models explained 34–
36% of the variations in pO2. BMI, NC, and WC were also
significantly associated with pCO2 (all P values<0.05).
There was no significant association between waist-to-hip
ratio and blood gases (both P values>0.27).
Conclusions Both central and overall obesity were associ-
ated with unfavorable blood gases and low ERV.
Keywords Lung function.Anthropometry.Obesity.Blood
gases
Abbreviation
COPD Chronic obstructive pulmonary disease
DLCO Diffusing capacity for carbon monoxide
ERV Expiratory reserve volume
FEV1 Forced expiratory volume the first second
FRC Functional residual capacity
FVC Forced vital capacity
HC Hip circumference
IC Inspiratory capacity
ITGV Intrathoracic gas volume
NC Neck circumference
TLC Total lung capacity
VA Alveolar lung volume
VC Vital capacity
WC Waist circumference
WHR Waist-to-hip ratio
RV Residual volume
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Obesity may cause adverse effects on the respiratory system
due to alterations in gas exchange, respiratory mechanics,
muscular endurance, and respiratory control [1]. These
effects may be linked to a variety of comorbidities such as
pulmonary hypertension, diastolic dysfunction, and coro-
nary heart disease. Obesity may also lead to respiratory
failure known as obesity hypoventilation syndrome [1].
Pulmonary gas exchange impairment at rest may increase
the risk of post-operative pulmonary complications and
have negative impact on obesity-related comorbidities.
It has been shown that obesity reduces thoracic wall
compliance by restricting diaphragm movement and tho-
racic cage expansion [2]. Lung compliance is also reduced
due to increased blood volume and a combination of
alveolar collapse and airway closing in the lung basis [3].
The effects of obesity on total lung capacity (TLC) and vital
capacity (VC) are modest, whereas functional residual
capacity (FRC) and particularly expiratory reserve volume
(ERV) may be severely decreased [1, 4–6]. An observa-
tional study of 37 morbidly obese patients showed that
massive weight loss following bariatric surgery was
associated with a significant improvement of ERV [7].
The effects of various patterns of obesity on pulmonary
function have been studied. In obese males, forced vital
capacity (FVC), forced expiratory volume (FEV1), and
TLC were lower in those with android obesity (i.e., upper
body obesity) than in those with gynecoid obesity (i.e.,
lower body obesity) [8]. It has also been suggested that
waist-to-hip ratio (WHR), rather than BMI, explains a large
part of the variance in pulmonary gas exchange [9, 10].
Current literature is scarce about the possible relationship
between various levels of obesity and pulmonary gas
exchange. If increasing levels of extreme obesity have
detrimental effects on pulmonary gas exchange, this might
have prognostic and therapeutic implications. We aimed to
investigate how various measures of overall and abdominal
obesity are related to arterial blood gases and pulmonary
function in a population of morbidly obese patients with
normal lung function.
Material and Methods
Study Design and Population
This is a cross-sectional analysis of baseline data from the
non-randomized controlled MOBIL study (Morbid Obesity
treatment, Bariatric surgery versus Intense Lifestyle inter-
vention; Clinical Trials.gov number NCT0027314), the
primary aim of which was to compare the effects of
lifestyle intervention and bariatric surgery on various
comorbidities. The study design, methods, and population
have been described in detail [11]. Briefly, 224 adult
morbidly obese subjects (BMI ≥40 or ≥35 kg/m
2 with a
weight-related comorbidity), predominantly of European
descent, were consecutively screened at our regional
tertiary care center. After exclusion of 47 subjects who
declined to participate or who had heavy comorbidities, 177
subjects were found potentially eligible for either lifestyle
intervention or bariatric surgery. As the aim of this substudy
was to explore the specific effects of obesity on blood gases
and lung function, 22 subjects with chronic obstructive
pulmonary disease (FEV1/FVC <70%) [12] and six sub-
jects with restrictive lung function impairment (FVC <80%
of predicted value and TLC <80% of predicted value) [13]
were excluded from further analyses. The remaining 149
subjects were defined as having normal lung function and
were included in the analysis.
All participants gave informed written consent before
enrolment. The study was approved by the Regional Ethics
Committee for Medical Research (S-05715).
Data Source and Measurements
All subjects were examined by a physician. Demographic
data and medical history, including smoking habits
(recorded as pack-years), and use of bronchodilators were
recorded. Height, weight, neck circumference (NC), waist
circumference (WC), and hip circumference (HC) were
measured with subjects in an upright position wearing light
clothes and no shoes. Indexes were calculated for BMI
(weight divided by the square of height, kilograms per
square meter (kg/m
2)) and WHR (WC divided by HC). NC
was measured at the cricoid cartilage and WC at the level
midway between the lowest rib margin and the iliac crest.
Blood gas samples were taken from the radial artery after
at least 5 min of rest and with the subjects in a sitting
position. The sampling was carried out by either a
physician (AMG) or two experienced nurses. For analyses
we used an ABL 735 Radiometer (Copenhagen, Denmark)
calibrated in accordance with the manufacturer's specifica-
tions. Arterial blood gas values for pO2<10.7 kPa
(80 mmHg) and for pCO2>6.0 kPa (45 mmHg) were
defined as abnormal [14].
Lung function measurements included dynamic spirom-
etry, static lung volumes, and gas diffusion capacity. All
tests were carried out by two experienced nurses according
to the guidelines recommended by the ATS-ERS task force
[15–17] and with subjects sitting in an upright position
wearing a nose clip. The Jaeger Master Lab (Eric Jaeger,
Wurzburg, Germany) was used in all tests and was
calibrated daily using a 1-L syringe. Recorded variables
were: FVC, FEV1, FEV1/FVC, diffusion capacity for
carbon monoxide (DLCO), DLCO divided by alveolar lung
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intrathoracic gas volume (ITGV), ERV, and residual
volume (RV).
The reference values for FVC, FEV1, DLCO, TLC, VC,
IC, ITGV, and RVare those recommended by the European
Respiratory Society (ERS) [13]. These reference values
have been derived from studies of healthy, non-smoking
adults of European descent [13]. However, since the ERS
offers no reference values for ERV, the Jaeger Master Lab
reference values were used instead. Sixteen lung volume
tests were rejected (12 due to technical problems and four
due to compliance problems), and one single breath test
was rejected (due to non-compliance). All tests were carried
out between 9 and 10A.M. No bronchodilator drug was
allowed prior to lung function testing.
Statistical Analysis
Independent samples t test or Mann-Whitney test were used
for the comparison of continuous data, whereas Chi-square
test was used for categorical data. Spearman's correlations
were calculated to assess bivariate relationships between
anthropometric measures, blood gases, and lung function
tests. Multiple linear regression analyses were used to
assess the effect of each anthropometric measure on arterial
blood gases after adjustment for confounding factors (age,
gender, pack-years). We fitted eight separate multiple linear
regression models with either pO2 or pCO2 as the
dependent variable, and either BMI, NC, WC, or WHR
as the independent variable adjusted for confounders. No
violation of the assumptions of normality or multicolli-
nearity was revealed in the models. Two-tailed P values are
reported, with P values below 0.05 considered statistically
significant. Semi-partial (part) correlation coefficients were
squared in order to estimate the percentage of total
variance in the dependent variable explained by a given
independent variable. The analyses were carried out using
SPSS 16.0 (SPSS, Chicago, IL).
Results
Demographic, clinical, and anthropometric characteristics
of the 149 morbidly obese patients are shown in Table 1.
Forty subjects (27%) had physician-diagnosed asthma and
had been prescribed brochodilators; 14 used on-demand
short acting bronchodilators, while 26 used the combination
of inhaled steroids and long acting beta-2-agonists.
The spirometry results, lung volumes, and blood gases
are shown in Table 2. All lung function values except ERV,
ITGV, and IC were within predicted range. The individual
pO2 and pCO2 values ranged from 7.7 kPa (58 mmHg) to
15.3 kPa (115 mmHg) and from 3.6 kPa (27 mmHg) to
6.5 kPa (49 mmHg), respectively. Forty-two patients (28%)
had abnormally low pO2 values (<10.7 kPa [80 mmHg])
and eight patients (5%) had abnormally high pCO2 values
(>6.0 kPa [45 mmHg]).
BMI, NC, and WC correlated significantly and nega-
tively with ERV (r=−0.25, −0.19 and −0.21, all p<0.05),
while NC correlated significantly and negatively with VC
(r=−0.23, p=0.007). WHR did not correlate significantly
with any lung volume index, and no significant correlations
were observed between anthropometrics measures and IC
or RV (data not shown).
Table 1 Demographic, anthropometric, and clinical characteristics of
149 morbidly obese patients
Variables Values
Females 114 (77)
Age [years] 43 (11)
Weight [kg] 130 (23)
BMI [kg/m
2] 45.0 (6.3)
Neck circumference [cm] 42 (4)
Waist circumference [cm] 133 (14)
Waist-to-hip ratio 0.97 (0.09)
Bronchodilator medication 40 (27)
Never-smokers 61 (41)
Pack-years 9 (13)
Values are given as mean (SD) or n (%)
Table 2 Lung function and arterial blood gases in 149 morbidly
obese patients
Variables Values
Spirometry
Forced vital capacity 103 (15)
Forced expiratory volume the first second 97 (15)
Gas diffusing capacity
Diffusing capacity for carbon monoxide [DLCO] 91 (14)
DLCO divided by alveolar lung volume 105 (16)
Static lung volumes
Total lung capacity 98 (12)
Vital capacity 101 (15)
Inspiratory capacity 123 (22)
Intrathoracic gas volume 78 (16)
Expiratory reserve volume 49 (34)
Residual volume 96 (28)
Blood gases and pH
pCO2 [kPa/mmHg] 5.2/39 (0.5/4)
pO2 [kPa/mmHg] 11.5/87 (1.5/11)
pH 7.41 (0.02)
Except for blood gases, values are referred as “percent predicted” and
given as mean (SD)
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correlated significantly with decreasing pO2 (all P values
<0.01), and increasing pCO2 (all P values<0.05).
ERV and RV correlated significantly with pO2 and
pCO2 (Fig. 2).
The multiple linear regression analyses showed that
increasing levels of BMI, WC, and NC were significantly
associated with decreasing pO2 after adjustments for age,
gender, and pack-years (Tab 3). The three multivariate
models explained 34–36% of the variation in pO2. Based
on part correlations BMI explained 9%, and NC and WC
explained 6% of the variations in pO2.
Multiple linear regression (Table 3) showed that increas-
ing BMI, NC, and WC were significantly associated with
increasing pCO2. The three models explained 20–23% of
the variation in pCO2. Based on part correlations BMI
explained 6%, and NC and WC explained 3% of the
variations in pCO2. There were no significant associations
between WHR and blood gases in the multivariable
analyses.
Discussion
Key Results
The main and novel findings of this study are that both
measures of overall (BMI) and central obesity (WC, NC)
were significantly associated with lower pO2 and higher
pCO2 among morbidly obese subjects with normal lung
function. In addition, BMI, NC, and WC correlated
negatively with ERV.
Fig. 1 The scatter plots show the relationship between anthropometric measures and blood gases
488 OBES SURG (2011) 21:485–491Interpretation
Our results are partly in contrast to those of Zavorsky et al.
[9] who found that increasing WHR, but not BMI, was
associated with detrimental changes in blood gas values.
This discrepancy might have several explanations. Firstly,
the previous study was small (n=25) and included a
heterogeneous sample of subjects with either normal (n=
18) or abnormal (n=7) lung function, but the analysis was
not stratified according to lung function. Conversely, we
examined 149 subjects, all with normal lung function.
Secondly, in contrast to our study, clinically relevant
confounding factors were neither addressed nor adjusted
for in the previous study. Notably, we too could demon-
strate statistically significant associations between WHR
and blood gases in the univariate analyses, but these
associations did not remain significant after adjustment for
gender, age, and pack-years.
Our findings partly confirm the preliminary results from
a cross-sectional study of 76 morbidly obese Chinese
subjects that showed a significant association between
BMI and blood gases [18]. Our results extend those
findings to be valid in white morbidly obese patients
independent of confounding factors. No measure of central
obesity was addressed in the Chinese study.
Another more recent cross-sectional study of 150
morbidly obese Chinese adults with normal lung function
demonstrated that only WC—in contrast to BMI and WHR
—was associated with reductions in FEV1, FVC, TLC, and
VC [19]. However, this study did not address the
relationship between anthropometric measures and arterial
blood gases.
Fig. 2 The scatter plots show the relationship between expiratory reserve volume, residual volume, and blood gases
Table 3 The relationship between various anthropometric measures and arterial blood gases in 149 morbidly obese subjects with normal lung
function
Dependent variables Independent variables Standardized beta P values R-square
pO2 BMI −0.292 <0.001 0.36
NC −0.317 <0.001 0.34
WC −0.270 <0.001 0.36
WHR −0.096 0.268 0.29
pCO2 BMI 0.250 0.001 0.23
NC 0.225 0.023 0.20
WC 0.205 0.014 0.20
WHR 0.031 0.739 0.17
Each anthropometric measure was adjusted for age, gender, and pack-years in eight separate multiple linear regression analyses
BMI denotes body mass index, NC neck circumference, WC waist circumference, WHR waist-to-hip ratio
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Abdominal fat raises intra-abdominal pressure causing
cephalad movement of the diaphragm, and thus reducing
chest volume. Morbidly obese subjects have an abnormally
high alveolar-to-arterial oxygen partial pressure difference
and reduced pO2 [9, 10], which reflects a ventilation–
perfusion mismatch as the lower parts of the lungs are
underventilated and overperfused in obese subjects.
Accordingly, profound weight loss after bariatric surgery
has been associated with increased pO2 [7, 10]. Both WC
and BMI reflect the amount of abdominal fat [20], and
consequently increasing BMI and WC may be associated
with atelectases and ventilation-perfusion mismatching,
which may have an impact on blood gases.
In accordance with a previous study of morbidly obese
patients, most lung function values were within predicted
range whilst the mean ERV was less than 50% of predicted
value [21].
Further, ERV was significantly correlated with BMI, NC,
and WC. A decrease in ERV may lead to a decrease in FRC
which in turn may fall below closing volume. Thus, morbidly
obese subjects breathe near their residual volume. The
collapse of small airways leads to increasing V/Q mismatch
and hypoxia as described above. The relationship between
reduced ERV and hypoxia in morbidly obese subjects has
previously been shown [7]. In a study aimed to assess the
effects of BMI on lung volumes [22], FRC and ERV were
found to decrease exponentially with increasing BMI, and
the greatest effects were on subjects with BMI >30 kg/m
2.
Notably, both FRC and ERV were significantly lower in
moderately obese women and men (BMI, 30–35 kg/m
2) than
in their normal weight counterparts (BMI, 20–25 kg/m
2)o f
comparable age. In this way, even moderate obesity lead to
decreased ERV which may affect blood gases.
Notably, although we excluded patients with abnormal
lung function from the present analysis, one out of four
patients (27%) had been prescribed bronchodilator drugs
due to asthma as diagnosed by their physician. This
finding is in line with a previous study which reported a
prevalence of asthma of 24% among morbidly obese
subjects [21]. Several biological mechanisms may explain
the relationship between asthma and obesity including
those referred above [23].
Generalizability and Possible Implications
Our study demonstrates that in morbidly obese subjects,
increasing levels of obesity are associated with worsening
of blood gases. This could imply that clinicians should use
spirometry and blood gas analyses to identify morbidly
obese patients at particularly high risk for post-operative
complications—for instance after bariatric surgery. Conse-
quently, it might be wise to measure lung function and
blood gases routinely in this patient group.
Limitations
Our study has limitations. Firstly, the cross-sectional design
is unsuitable for establishing a cause–effect relationship.
Secondly, our results may not be valid in non-white
populations. Finally, we cannot exclude the possibility that
the referral of patients to a tertiary care center might have
introduced a sampling bias which may limit the generaliz-
ability of our results.
Conclusion
Our study of white morbidly obese subjects with normal
lung function, demonstrates that increasing levels of BMI,
WC, and NC are significantly associated with decreasing
pO2 and increasing pCO2 even after adjustments for age,
gender, and pack-years. In addition, both central and overall
obesity are associated with low ERV.
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